Inhibition of this enzyme might be exploited for preventing and treating tumor diseases, such as BRCA1 and BRCA2 deficient tumors, including breast, ovarian, prostate, and pancreatic cancer. The gene discussed is BRCA1; the disease is pancreatic neoplasm.